AbbVie Inc. against Eli Lilly and Company — live side-by-side technical comparison.
Prices as of 2026-10-09T20:01:20+00:00 UTC · updates daily
ABBV leads 5 of the 5 windows we measure — over 1 month ABBV is +10.2% and LLY +4.9%; over year to date ABBV is +21.0% and LLY +9.7%. The ABBV/LLY price ratio stands at 0.2344, above its 50-day average of 0.2207, and above the 200-day average of 0.2165. A ratio above its own average means ABBV is gaining on LLY; on this reading the recent edge belongs to ABBV.
| ABBV | LLY | |
|---|---|---|
| Price | $276.47 | $1179.27 |
| 1 day | +1.5%lead | +0.8% |
| 5 days | +5.2%lead | +3.2% |
| 1 month | +10.2%lead | +4.9% |
| 6 months | +30.2%lead | +23.5% |
| Year to date | +21.0%lead | +9.7% |
| 52-week position | 99% of range | 78% of range |
| 52-week range | $190.75–$277.60 | $783.85–$1292.65 |
| vs 50-day average | above $258.89 | above $1173.97 |
| vs 200-day average | above $232.65 | above $1076.50 |
| RSI (14) | 73 | 54 |
| Next earnings | 2026-10-30 | 2026-10-29 |
ABBV trades at $276.47, above its 50-day average of $258.89, and above the 200-day at $232.65. It sits at 99% of its 52-week range ($190.75–$277.60); 14-day RSI is 73, in overbought territory; an average session moves it about 2.1%. For levels, the first level overhead is $300.00 (8.5% away) and the first support below is $275.00 (0.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
LLY trades at $1,179.27, above its 50-day average of $1,173.97, and above the 200-day at $1,076.50. It sits at 78% of its 52-week range ($783.85–$1,292.65); 14-day RSI is 54, in neutral territory; an average session moves it about 3.1%. For levels, the first level overhead is $1,200.00 (1.8% away) and the first support below is $1,173.97 (0.5% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
LLY is the more volatile of the two — an average session moves it 3.1% against 2.1% for ABBV, so an identical position size carries roughly 1.5× the daily risk.
The comparison turns on those levels: ABBV clearing $300.00 or losing $275.00; LLY clearing $1,200.00 or losing $1,173.97. Until one of them gives way, the relative reading above stands.